NYSE:PBYI

Puma Biotechnology Stock Forecast

etoro logo Buy PBYI
*Your capital is at risk
$7.33
+0.1000 (+1.38%)
At Close: Jun 12, 2026
AI Analysis AI Analysis of PBYI AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add PBYI to Watchlist?
Some Reasons Why To Add PBYI:
  • Beat earnings estimates in all of the last 4 quarters
  • +118.8% price growth over the last year
  • Excellent financial health (Piotroski 7/9)
PDF

Puma Biotechnology Inc stock price up 1.38% on Friday
(Updated on Jun 12, 2026)

Buy candidate since Jun 11, 2026 Gain 1.38%

The Puma Biotechnology Inc stock price gained 1.38% on the last trading day (Friday, 12th Jun 2026), rising from $7.23 to $7.33. During the last trading day the stock fluctuated 5.01% from a day low at $6.98 to a day high of $7.33. The price has been going up and down for this period, and there has been a 2.23% gain for the last 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 91 thousand more shares were traded than the day before. In total, 260 thousand shares were bought and sold for approximately $1.91 million.

The stock lies in the middle of a wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 10.65% during the next 3 months and, with a 90% probability hold a price between $7.42 and $9.27 at the end of this 3-month period.

PBYI Signals & Forecast

The Puma Biotechnology Inc stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down, there will be some support from the lines at $7.07 and $7.19. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Thursday, April 09, 2026, and so far it has fallen -6.03%. Further fall is indicated until a new bottom pivot has been found.

Support, Risk & Stop-loss for Puma Biotechnology Inc stock

Puma Biotechnology Inc finds support from accumulated volume at $7.24 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock is usually traded at a good volume, and with minor daily changes, the risk is considered to be low. During the last day, the stock moved $0.350 (5.01%) between high and low. For the last week, the stock has had daily average volatility of 4.37%.

Our recommended stop-loss: $6.90 (-5.86%) (This stock has low daily movements and this gives low risk. There is a sell signal from a pivot top found 45 days ago.)

Trading Expectations (PBYI) For The Upcoming Trading Day Of Monday 15th

For the upcoming trading day on Monday, 15th we expect Puma Biotechnology Inc to open at $7.21, and during the day (based on 14 day Average True Range), to move between $7.19 and $7.47, which gives a possible trading interval of +/-$0.276 (+/-3.83%) up or down from last closing price. If Puma Biotechnology Inc takes out the full calculated possible swing range there will be an estimated 3.83% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $7.24 (1.23%) than the resistance at $7.49 (2.18%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Puma Biotechnology Inc stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Puma Biotechnology Inc stock to perform well in the short-term.

Current score: 1.625 Buy Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on June 15, 2026 - $7.21 ( 1.59%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

PBYI Performance

Trading levels for PBYI

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 7.56 3.18%
R2 7.43 1.36%
R1 7.35 0.232%
Price 7.33
S1 7.08 -3.42%
S2 7.00 -4.54%
S3 6.86 -6.37%

Accumulated Volume Support & Resistance Levels

Level Price
R3 7.57 3.27%
R2 7.51 2.46%
R1 7.49 2.18%
Price 7.33
S1 7.24 -1.23%
S2 7.08 -3.41%
S3 6.81 -7.09%

FAQ

What is the symbol for Puma Biotechnology Inc Stock and on which exchange is it traded?
The symbol for Puma Biotechnology Inc is PBYI and it is traded on the NYSE (New York Stock Exchange).

Should I buy or sell Puma Biotechnology Inc Stock?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Puma Biotechnology Inc stock to perform well in the short-term.

How to buy Puma Biotechnology Inc Stock?
Puma Biotechnology Inc Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Puma Biotechnology Inc Stock.

What's the current price of Puma Biotechnology Inc Stock?
As of the end of day on the Jun 12, 2026, the price of an Puma Biotechnology Inc (PBYI) share was $7.33.

What is the 52-week high and low for Puma Biotechnology Inc Stock?
The 52-week high for Puma Biotechnology Inc Stock is $7.90 and the 52-week low is $3.04.

What is the market capitalization of Puma Biotechnology Inc Stock?
As of the Jun 12, 2026, the market capitalization of Puma Biotechnology Inc is 373.093M.

When is the next earnings date for Puma Biotechnology Inc?
The upcoming earnings date for Puma Biotechnology Inc is Aug 06, 2026.
Click to get the best stock tips daily for free!
ABOUT PUMA BIOTECHNOLOGY INC
Puma Biotechnology
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for the use of neratinib in combination with capecitabine for the treatment of adult patients with advance...
GOLDEN STAR
Ticker Change Signal Date
EAT
$140.46
13.43% Jun 05
TPR
$140.47
4.95% Jun 04
LITE
$905.00
1.83% Jun 01
RUN
$12.83
0.468% May 06
GLBE
$31.61
3.54% May 05

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE